Hyderabad: Granules India Limited has inaugurated two advanced Centres of Excellence at the Technology Research Park of IIT ...

A novel biologic treatment, ILUMYA (Tildrakizumab) has been endorsed widely by dermatologists in the US and worldwide for ...

Sun Pharmaceutical Industries announced the launch of its global innovative drug, ILUMYA (Tildrakizumab) in India for moderate-to-severe plaque psoriasis. A novel biologic treatment, ILUMYA has been ...

Under the new arrangement, AstraZeneca and Sun Pharma will each market and distribute SZC under separate brand names.

From generics dominance to innovation leadership, India’s pharmaceutical sector is scaling rapidly through advanced ...

Brokerages like Citi and Choice Institutional Equities are optimistic about the pharmaceutical and flexible workspace sectors ...

“As the proportion of the 60-plus population increases, their contribution to the Indian pharma market will rise sharply. I ...

The 2nd PHARMAINNOVATE SUMMIT 2025 an International Conference on “From Molecule to Medicine: Drug Development, Drug Delivery ...

Shares of Sudeep Pharma on Friday made a strong debut on Indian stock exchanges.The shares listed at Rs 730 per unit on NSE ...

Emcure Pharma and Novo Nordisk India also announced a strategic partnership to launch Poviztra, semaglutide injection 2.4 mg, in India. “The collaboration will strengthen the distribution and ...